Article
Multidrug-resistant Escherichia coli bacteremia in cancer patients.
American journal of infection control - 1 Nov 2009
Vigil Karen J, Adachi Javier A, Aboufaycal Halim, Hachem Ray Y, Reitzel Ruth A, Jiang Ying, Tarrand Jeffrey J, Chemaly Roy F, Bodey Gerald P, Rolston Kenneth V, Raad Isaam
Abstract excerpt
BACKGROUND: Multidrug-resistant (MDR) Escherichia coli is a serious threat to cancer patients. We aimed to determine the risk factors associated with the development of MDR E coli bacteremia in cancer patients and the possibility of horizontal transmission. METHODS: We conducted a 1:2 case-control study of 58 patients with MDR E coli bacteremia. The patient's demographics, clinical characteristics, and antibiotic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
